开发一种多变量风险预测工具,预测1型糖尿病儿童的不良结果:试点研究
Fiona Lieu1, Wrivu N Martin2, Stewart Birt1,3
1The Central Coast Clinical School, School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.
Pediatric diabetes
|April 30, 2025
概括
这项研究为患有1型糖尿病 (T1DM) 的儿童开发了一种风险模型,以预测严重的低血糖,高血糖和糖尿病酸 (DKA) 住院情况. 该模型准确地识别了需要更密切监测的高风险儿科患者.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 糖尿病管理 糖尿病管理
- 临床风险预测预测
背景情况:
- 患有1型糖尿病 (T1DM) 的儿童和青少年因严重的低血糖症,高血糖症和糖尿病酸症 (DKA) 经常需要住院治疗.
- 鉴定急性脱补偿的高风险儿科患者仍然是一个临床挑战.
研究的目的:
- 开发和验证一种风险预测模型,用于儿童T1DM患者的急性医疗保健利用.
- 准确估计严重低血糖,高血糖和DKA相关住院的风险.
主要方法:
- 从患有T1DM的儿科患者 (<18岁) 进行回顾性数据收集.
- 使用后勤回归的多变量风险预测模型的开发.
- 使用ROC曲线和Kaplan-Meier时间到事件分析评估模型歧视.
主要成果:
- 开发了一个五个预测模型 (持续的葡萄糖监测,先前的急性护理,错过的预约,儿童福利参与,社会经济地位).
- 该模型显示出良好的区别 (AUC = 0.81) 并准确地将患者分为风险组.
- 在风险层之间观察到急性医疗利用时间的显著差异.
结论:
- 开发的风险预测模型有效地识别了患有急性医疗利用风险增加的儿科T1DM患者.
- 这种工具可以帮助高风险个人主动管理和干预.
- 进一步的研究可以完善该模型,使其具有更广泛的临床应用.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications
471
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
471
Pathophysiology of Diabetes
805
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
805
Insulin: Dosing Regimen and Adverse Effects
121
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
121
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106


